Evidence for the outcomes and impact of clinical pharmacy: context of UK hospital pharmacy practice
Onatade, Raliat, Appiah, Sandra S. ORCID: https://orcid.org/0000-0002-7497-3388, Stephens, Martin and Garelick, Hemda
ORCID: https://orcid.org/0000-0003-4568-2300
(2018)
Evidence for the outcomes and impact of clinical pharmacy: context of UK hospital pharmacy practice.
European Journal of Hospital Pharmacy, 25
(e1)
.
e21-e28.
ISSN 2047-9956
[Article]
(doi:10.1136/ejhpharm-2017-001303)
|
PDF
- Final accepted version (with author's formatting)
Download (1MB) | Preview |
Abstract
Objectives: The role of clinical pharmacists in hospitals has evolved and continues to expand. In the UK, outside of a few national policy drivers, there are no agreed priorities, measures or defined outcomes for hospital clinical pharmacy (CP). This paper aims to (1) highlight the need to identify and prioritise specific CP roles, responsibilities and practices that will bring the greatest benefit to patients and health systems and (2) describe systematic weaknesses in current research methodologies for evaluating CP services and propose a different approach.
Method: Published reviews of CP services are discussed using the Economic, Clinical and Humanistic Outcomes framework. Recurring themes regarding study methodologies, measurements and outcomes are used to highlight current weaknesses in studies evaluating CP.
Results: Published studies aiming to demonstrate the economic, clinical or humanistic outcomes of CP often suffer from poor research design and inconsistencies in interventions, measurements and outcomes. This has caused difficulties in drawing meaningful conclusions regarding CP’s definitive contribution to patient outcomes.
Conclusion: There is a need for more research work in National Health Service (NHS) hospitals, employing a different paradigm to address some of the weaknesses of existing research on CP practice. We propose a mixed-methods approach, including qualitative research designs, and with emphasis on cost-consequence analyses for economic evaluations. This approach will provide more meaningful data to inform policy and demonstrate the contribution of hospital CP activities to patient care and the NHS.
Item Type: | Article |
---|---|
Research Areas: | A. > School of Science and Technology > Natural Sciences |
Item ID: | 22972 |
Notes on copyright: | This is the author’s manuscript, the final version of record is published in European Journal of Hospital Pharmacy available from BMJ at: http://dx.doi.org/10.1136/ejhpharm-2017-001303
© European Association of Hospital Pharmacists (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. |
Useful Links: | |
Depositing User: | Sandra Appiah |
Date Deposited: | 20 Nov 2017 13:02 |
Last Modified: | 29 Nov 2022 20:04 |
URI: | https://eprints.mdx.ac.uk/id/eprint/22972 |
Actions (login required)
![]() |
View Item |
Statistics
Additional statistics are available via IRStats2.